Skip to main content
. 1999 Sep 28;96(20):11482–11485. doi: 10.1073/pnas.96.20.11482

Figure 4.

Figure 4

Sequential treatment of HIV-infected PBMCs with the anti-CD25 IT followed by either the anti-CD45RO IT or the anti-CD45RA IT. PBMCs were treated as described in Fig. 1 and p24 levels were determined. (A, nine experiments) PBMCs cultured in CM followed by treatment with the anti-CD45RO IT (column 1); PBMCs treated with the anti-CD25 IT followed by CM (column 2); PBMCs treated with the anti-CD25 IT followed by the anti-CD45RO IT (column 3). (B, six experiments) PBMCs treated with the anti-CD25 IT followed by CM (column 4); PBMCs treated with the anti-CD25 IT followed by the anti-CD45RA IT (column 5).